Clinical Trial Update: An Extension Study of LON002 in Patients With Cancer [NA]

View source ↗

Summary

This clinical trial update covers an extension study of LON002 in cancer patients; no phase information is provided and the status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• LON002

Snippet

Sponsor: LondonPharma Ltd. | Conditions: Solid Tumours | NA | Status: UNKNOWN